ZVRA — ZEVRA THERAPEUTICS INC

Ownership history in EntryPoint Capital, LLC  ·  4 quarters on record

This page tracks every 13F SEC filing in which EntryPoint Capital, LLC reported a position in ZEVRA THERAPEUTICS INC (ZVRA). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.18% (2025 Q4)
Avg. % of fund
0.13%
First filed
2024 Q4
Last filed
2025 Q4
Quarters held
4
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 52,871 +23,989 +83.1% 0.18% $474K $8.96
2025 Q3 REDUCED 28,882 -11,793 -29.0% 0.11% $275K $9.51
2025 Q1 ADDED 40,675 +14,225 +53.8% 0.14% $305K $7.49
2024 Q4 INITIATED 26,450 — — 0.09% $221K $8.34
% of Fund (quarterly)    ZVRA price (monthly, adj. close)

Other funds also holding ZVRA

As of 2025 Q4 — sorted by position size

Stonepine Capital Management, LLC 3Y 7Y 3.72% Mystic Asset Management, Inc. 3Y 0.7% KINGDON CAPITAL MANAGEMENT, L.L.C. 3Y 7Y 0.62% Nantahala Capital Management, LLC 3Y 7Y 0.52% Propel Bio Management, LLC 0.49% Tetragon Partners GP Ltd 3Y 7Y 0.36% 683 Capital Management, LLC 3Y 7Y 0.35% STONERIDGE INVESTMENT PARTNERS LLC 3Y 7Y 0.2% Woodline Partners LP 3Y 0.12% Kovack Advisors, Inc. 3Y 7Y 0.12%
← Back to EntryPoint Capital, LLC Holdings